Share

August 2015; 2 (4) Clinical/Scientific NotesOpen Access

Posterior cortical and white matter changes on MRI in anti–AMPA receptor antibody encephalitis

Marwa Elamin, Roisin Lonergan, Ronan P. Killeen, Sean O'Riordan, Niall Tubridy, Christopher McGuigan
First published May 21, 2015, DOI: https://doi.org/10.1212/NXI.0000000000000118
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
756

Share

Article Information

vol. 2 no. 4 e118
DOI: 
https://doi.org/10.1212/NXI.0000000000000118
PubMed: 
26090507
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received December 29, 2014
  • Accepted in final form April 19, 2015
  • First Published May 21, 2015.
Copyright & Usage: 
© 2015 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 4.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Marwa Elamin, PhD, MRCP,
    2. Roisin Lonergan, MD,
    3. Ronan P. Killeen, MD,
    4. Sean O'Riordan, MD,
    5. Niall Tubridy, MD and
    6. Christopher McGuigan, MD
  1. Marwa Elamin, PhD, MRCP,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Roisin Lonergan, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. 1) Biogen Idec, travel to A.A.N.in Seattle 2009 2) Schering, travel to ECTRIMS in Dusseldorf, 2009 3) Sanofi-Aventis, travel to WCTRIMS in Montreal, 2008 4) Educational talk to Novartis, 2015

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Ronan P. Killeen, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. Dublin Cyberknife Financing Limited. 2012 to date.

    Legal Proceedings:

    1. NONE

  4. Sean O'Riordan, MD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Dr Sean O?Riordan has received academic travel grants from Novartis and Abbvie; Honoraria for speaking engagements from Abbvie and Lundbeck and research funding support from Novartis and Dystonia Ireland.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Niall Tubridy, MD and
    6. Scientific Advisory Boards:

    1. I have received payment for Chairing Novartis Advisory Boards

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Sponsored to attend educational meetings by Sanofi Aventis, Novartis and Bayer Schering

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Christopher McGuigan, MD
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Biogen Idec, Travel Grant Biogen Idec, Honoraria for talks Novartis, Travel Grant

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Biogen Idec Genzyme Novartis

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From Trinity Biomedical Sciences Institute (M.E.) and St. Vincent's University Hospital (R.L., R.P.K., S.O., N.T., C.M.), Dublin, Ireland.
  1. Correspondence to Dr. Elamin: marwaelamin08{at}gmail.com
View Full Text

Article usage

Article usage: May 2015 to February 2023

AbstractFullPdfSource
May 201552258Highwire
Jun 20151172124Highwire
Jun 20150146pmc
Jul 20151361117Highwire
Jul 201502613pmc
Aug 20151573050Highwire
Aug 20150144pmc
Sep 20152138Highwire
Sep 20150195pmc
Oct 201530125Highwire
Oct 20150167pmc
Nov 2015853Highwire
Nov 2015094pmc
Dec 2015641Highwire
Dec 201501711pmc
Jan 20162063Highwire
Jan 20160133pmc
Feb 20161258Highwire
Feb 20160149pmc
Mar 20162325Highwire
Mar 2016093pmc
Apr 2016732Highwire
Apr 2016051pmc
May 20161741Highwire
May 2016065pmc
Jun 20162131Highwire
Jun 2016073pmc
Jul 20162963Highwire
Jul 2016054pmc
Aug 20161315Highwire
Aug 2016051pmc
Sep 20161682Highwire
Sep 2016053pmc
Oct 20161833Highwire
Oct 2016042pmc
Nov 2016816Highwire
Nov 20160101pmc
Dec 2016710Highwire
Dec 2016090pmc
Jan 20171032Highwire
Jan 2017040pmc
Feb 2017931Highwire
Feb 2017061pmc
Mar 2017843Highwire
Mar 20170104pmc
Apr 2017423Highwire
Apr 2017522pmc
May 2017413Highwire
May 20173910pmc
Jun 2017421Highwire
Jun 2017478pmc
Jul 2017020Highwire
Jul 201731112pmc
Aug 2017826Highwire
Aug 2017144pmc
Sep 2017943Highwire
Sep 2017099pmc
Oct 2017412Highwire
Oct 201741210pmc
Nov 2017943Highwire
Nov 2017066pmc
Dec 2017072Highwire
Jan 20180176Highwire
Feb 20183124Highwire
Mar 20181182Highwire
Apr 20180133Highwire
Apr 2018177pmc
May 20181193Highwire
Jun 20182255Highwire
Jun 2018177pmc
Jul 20181164Highwire
Aug 20181173Highwire
Aug 2018255pmc
Sep 20180201Highwire
Oct 20183265Highwire
Nov 20181290Highwire
Dec 20181214Highwire
Jan 20193193Highwire
Feb 20190254Highwire
Mar 20192154Highwire
Apr 2019388Highwire
May 20196254Highwire
Jun 20196132Highwire
Jul 201942512Highwire
Aug 20193197Highwire
Sep 20191175Highwire
Oct 201912236Highwire
Nov 20190184Highwire
Dec 20192213Highwire
Jan 20206157Highwire
Feb 20201153Highwire
Mar 202021210Highwire
Apr 2020031Highwire
May 20201185Highwire
Jun 20202157Highwire
Jul 20200223Highwire
Aug 2020172Highwire
Sep 20202187Highwire
Oct 20202354Highwire
Nov 202031122Highwire
Dec 20204159Highwire
Jan 202151015Highwire
Feb 20214186Highwire
Mar 20217255Highwire
Apr 202161811Highwire
May 20210184Highwire
Jun 20210287Highwire
Jul 202142110Highwire
Aug 20213248Highwire
Sep 202111810Highwire
Oct 202103116Highwire
Nov 202103221Highwire
Dec 202124112Highwire
Jan 20221214Highwire
Feb 20223234Highwire
Mar 20221352Highwire
Apr 20220332Highwire
May 20220348Highwire
Jun 202212211Highwire
Jul 20220264Highwire
Aug 20223362Highwire
Sep 20220359Highwire
Oct 202245012Highwire
Nov 202218214Highwire
Dec 20220317Highwire
Jan 202314710Highwire
Feb 20230336Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles